Targeted delivery of immunogen to primate M cells with tetragalloyl lysine dendrimer

Journal of Immunology

Volumn 182, Issue 10, 2009, Pages 6061-6070

  Misumi, Shogo ^a   Masuyama, Mitsuaki ^a,b   Takamune, Nobutoki ^a   Nakayama, Daisuke ^a   Mitsumata, Ryotarou ^a   Matsumoto, Hirokazu ^a   Urata, Norimitsu ^a   Takahashi, Yoshihiro ^b   Muneoka, Atsunobu ^b   Sukamoto, Takayuki ^b   Fukuzaki, Koichiro ^b   Shoji, Shozo ^a,c  

^a KUMAMOTO UNIVERSITY   (Japan)

^b SHIN NIPPON BIOMEDICAL LABORATORIES LTD   (Japan)

^c KUMAMOTO HEALTH SCIENCE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CHEMOKINE RECEPTOR CCR5 DERIVED CYCLOPEPTIDE; DENDRIMER; IMMUNOGLOBULIN A; PEPTIDE DERIVATIVE; TETRAGALLOYL DEXTRO LYSINE DENDRIMER; UNCLASSIFIED DRUG; VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; FECES; FEMALE; GERMINAL CENTER; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOCOMPETENT CELL; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; INTESTINE; MACACA; NONHUMAN; PEYER PATCH; PRIMATE; PRIORITY JOURNAL; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; TARGET CELL; TRANSCYTOSIS; VACCINATION;

ANIMALS; ANTIGENS; CACO-2 CELLS; DENDRIMERS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNITY, MUCOSAL; LYSINE; MACACA MULATTA; MICROSCOPY, ELECTRON, TRANSMISSION; PEYER'S PATCHES; RECEPTORS, CCR5; SIMIAN IMMUNODEFICIENCY VIRUS; VACCINATION; VACCINES;

EID: 77950469136     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0802928     Document Type: Article

References (55)

1. Pope, M., and A. T. Haase. 2003. Transmission, acute HIV-1 infection and the quest for strategies to prevent infection. Nat. Med. 9: 847-852. (Pubitemid 36889925)
2. Lackner, A. A., and R. S. Veazey. 2007. Current concepts in AIDS pathogenesis: insights from the SIV/macaque model. Annu. Rev. Med. 58: 461-476.
3. + T cells. Nature 434: 1148-1152.
4. + T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J. Virol. 77: 11708-11717.
5. Mascola, J. R., G. Stiegler, T. C. VanCott, H. Katinger, C. B. Carpenter, C. E. Hanson, H. Beary, D. Hayes, S. S. Frankel, D. L. Birx, and M. G. Lewis. 2000. Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat. Med. 6: 207-210.
6. Belyakov, I. M., B. Moss, W. Strober, and J. A. Berzofsky. 1999. Mucosal vaccination overcomes the barrier to recombinant vaccinia immunization caused by preexisting poxvirus immunity. Proc. Natl. Acad. Sci. USA 96: 4512-4517.
7. Gherardi, M. M., E. Perez-Jimenez, J. L. Najera, and M. Esteban. 2004. Induction of HIV immunity in the genital tract after intranasal delivery of a MVA vector: enhanced immunogenicity after DNA prime-modified vaccinia virus Ankara boost immunization schedule. J. Immunol. 172: 6209-6220.
8. Douce, G., V. Giannelli, M. Pizza, D. Lewis, P. Everest, R. Rappuoli, and G. Dougan. 1999. Genetically detoxified mutants of heat-labile toxin from Escherichia coli are able to act as oral adjuvants. Infect. Immun. 67: 4400-4406. (Pubitemid 29400413)
9. Belyakov, I. M., S. A. Hammond, J. D. Ahlers, G. M. Glenn, and J. A. Berzofsky. 2004. Transcutaneous immunization induces mucosal CTLs and protective immunity by migration of primed skin dendritic cells. J. Clin. Invest. 113: 998-1007.
10. Kang, S. M., Q. Yao, L. Guo, and R. W. Compans. 2003. Mucosal immunization with virus-like particles of simian immunodeficiency virus conjugated with cholera toxin subunit B. J. Virol. 77: 9823-9830. (Pubitemid 37122063)
11. Guo, L., X. Lu, S. M. Kang, C. Chen, R. W. Compans, and Q. Yao. 2003. Enhancement of mucosal immune responses by chimeric influenza HA/SHIV virus-like particles. Virology 313: 502-513. (Pubitemid 37040690)
12. Sakaue, G., T. Hiroi, Y. Nakagawa, K. Someya, K. Iwatani, Y. Sawa, H. Takahashi, M. Honda, J. Kunisawa, and H. Kiyono. 2003. HIV mucosal vaccine: nasal immunization with gp160-encapsulated hemagglutinating virus of Japan-liposome induces antigen-specific CTLs and neutralizing antibody responses. J. Immunol. 170: 495-502. (Pubitemid 36026176)
13. Wang, X., D. M. Hone, A. Haddad, M. T. Shata, and D. W. Pascual. 2003. M cell DNA vaccination for CTL immunity to HIV. J. Immunol. 171: 4717-4725. (Pubitemid 37310589)
14. Holmgren, J., C. Czerkinsky, K. Eriksson, and A. Mharandi. 2003. Mucosal immunization and adjuvants: a brief overview of recent advances and challenges. Vaccine 21(Suppl. 2): S89-S95. (Pubitemid 36588654)
15. Kraehenbuhl, J. P., and M. R. Neutra. 2000. Epithelial M cells: differentiation and function. Annu. Rev. Cell. Dev. Biol. 16: 301-332.
16. Jepson, M. A., M. A. Clark, N. Foster, C. M. Mason, M. K. Bennett, N. L. Simmons, and B. H. Hirst. 1996. Targeting to intestinal M cells. J. Anat. 189: 507-516.
17. Clark, M. A., M. A. Jepson, and B. H. Hirst. 1995. Lectin binding defines and differentiates M-cells in mouse small intestine and caecum. Histochem. Cell Biol. 104: 161-168.
18. Jepson, M. A., C. M. Mason, M. A. Clark, N. L. Simmons, and B. H. Hirst. 1995. Variations in lectin binding properties of intestinal M cells. J. Drug Target 3: 75-77.
19. Clark, M. A., M. A. Jepson, N. L. Simmons, T. A. Booth, and B. H. Hirst. 1993. Differential expression of lectin-binding sites defines mouse intestinal M-cells. J. Histochem. Cytochem. 41: 1679-1687.
20. Clark, M. A., M. A. Jepson, N. L. Simmons, and B. H. Hirst. 1995. Selective binding and transcytosis of Ulex europaeus 1 lectin by mouse Peyer's patch M-cells in vivo. Cell Tissue Res. 282: 455-461.
21. Giannasca, P. J., K. T. Giannasca, P. Falk, J. I. Gordon, and M. R. Neutra. 1994. Regional differences in glycoconjugates of intestinal M cells in mice: potential targets for mucosal vaccines. Am. J. Physiol. 267: G1108-G1121.
22. Gebert, A., and W. Posselt. 1997. Glycoconjugate expression defines the origin and differentiation pathway of intestinal M-cells. J. Histochem. Cytochem. 45: 1341-1350. (Pubitemid 27402795)
23. Manocha, M., P. C. Pal, K. T. Chitralekha, B. E. Thomas, V. Tripathi, S. D. Gupta, R. Paranjape, S. Kulkarni, and D. N. Rao. 2005. Enhanced mucosal and systemic immune response with intranasal immunization of mice with HIV peptides entrapped in PLG microparticles in combination with Ulex europaeus-I lectin as M cell target. Vaccine 23: 5599-5617. (Pubitemid 41608610)
24. Wang, X., I. Kochetkova, A. Haddad, T. Hoyt, D. M. Hone, and D. W. Pascual. 2005. Transgene vaccination using Ulex europaeus agglutinin I (UEA-1) for targeted mucosal immunization against HIV-1 envelope. Vaccine 23: 3836-3842. (Pubitemid 40704748)
25. Wu, Y., X. Wang, K. L. Csencsits, A. Haddad, N. Walters, and D. W. Pascual. 2001. M cell-targeted DNA vaccination. Proc. Natl. Acad. Sci. USA 98: 9318-9323.
26. Lambkin, I., C. Pinilla, C. Hamashin, L. Spindler, S. Russell, A. Schink, R. Moya-Castro, G. Allicotti, L. Higgins, M. Smith, et al. 2003. Toward targeted oral vaccine delivery systems: selection of lectin mimetics from combinatorial libraries. Pharm. Res. 20: 1258-1266.
27. Takahashi, Y., S. Misumi, A. Muneoka, M. Masuyama, H. Tokado, K. Fukuzaki, N. Takamune, and S. Shoji. 2008. Nonhuman primate intestinal villous M-like cells: an effective poliovirus entry site. Biochem. Biophys. Res. Commun. 368: 501-507.
28. 178) of extracellular loop 2 in CCR5 as a novel human immunodeficiency virus type 1 vaccine. J. Virol. 75: 11614-11620.
29. Misumi, S., D. Nakayama, M. Kusaba, T. Iiboshi, R. Mukai, K. Tachibana, T. Nakasone, M. Umeda, H. Shibata, M. Endo, et al. 2006. Effects of immunization with CCR5-based cycloimmunogen on simian/HIVSF162P3 challenge. J. Immunol. 176: 463-471. (Pubitemid 43023292)
30. Gibellini, D., F. Vitone, E. Gori, M. La Placa, and M. C. Re. 2004. Quantitative detection of human immunodeficiency virus type 1 (HIV-1) viral load by SYBR green real-time RT-PCR technique in HIV-1 seropositive patients. J. Virol. Methods 115: 183-189.
31. Ui, M., T. Kuwata, T. Igarashi, K. Ibuki, Y. Miyazaki, I. L. Kozyrev, Y. Enose, T. Shimada, H. Uesaka, H. Yamamoto, et al. 1999. Protection of macaques against a SHIV with a homologous HIV-1 Env and a pathogenic SHIV-89.6P with a heterologous Env by vaccination with multiple gene-deleted SHIVs. Virology 265: 252-263. (Pubitemid 30022220)
32. Kernéis, S., A. Bogdanova, J. P. Kraehenbuhl, and E. Pringault. 1997. Conversion by Peyer's patch lymphocytes of human enterocytes into M cells that transport bacteria. Science 277: 949-952. (Pubitemid 27366679)
33. Clark, M. A., H. Blair, L. Liang, R. N. Brey, D. Brayden, and B. H. Hirst. 2001. Targeting polymerized liposome vaccine carriers to intestinal M cells. Vaccine 20: 208-217.
34. Hamashin, C., L. Spindler, S. Russell, A. Schink, I. Lambkin, D. O'Mahony, R. Houghten, and C. Pinilla. 2003. Identification of novel small-molecule Ulex europaeus I mimetics for targeted drug delivery. Bioorg. Med. Chem. 11: 4991-4997. (Pubitemid 37352986)
35. Veazey, R. S., M. Rosenzweig, D. E. Shvetz, D. R. Pauley, M. DeMaria, L. V. Chalifoux, R. P. Johnson, and A. A. Lackner. 1997. Characterization of gut-associated lymphoid tissue (GALT) of normal rhesus macaques. Clin. Immunol. Immunopathol. 82: 230-242.
36. Dustin, M. L., R. Rothlein, A. K. Bhan, C. A. Dinarello, and T. A. Springer. 1986. Induction by IL 1 and interferon-γ: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J. Immunol. 137: 245-254.
37. Koopman, G., H. K. Parmentier, H. J. Schuurman, W. Newman, C. J. Meijer, and S. T. Pals. 1991. Adhesion of human B cells to follicular dendritic cells involves both the lymphocyte function-associated antigen 1/intercellular adhesion molecule 1 and very late antigen 4/vascular cell adhesion molecule 1 pathways. J. Exp. Med. 173: 1297-1304.
38. Terahara, K., M. Yoshida, O. Igarashi, T. Nochi, G. S. Pontes, K. Hase, H. Ohno, S. Kurokawa, M. Mejima, N. Takayama, et al. 2008. Comprehensive gene expression profiling of Peyer's patch M cells, villous M-like cells, and intestinal epithelial cells. J. Immunol. 180: 7840-7846.
39. Sicinski, P., J. Rowinski, J. B. Warchol, Z. Jarzabek, W. Gut, B. Szczygiel, K. Bielecki, and G. Koch. 1990. Poliovirus type 1 enters the human host through intestinal M cells. Gastroenterology 98: 56-58. (Pubitemid 20017783)
40. Misumi, S., A. Eto, R. Mitsumata, M. Yamada, N. Takamune, and S. Shoji. 2008. Development of cell-expressed and virion-incorporated CCR5-targeted vaccine. Biochem. Biophys. Res. Commun. 377: 617-621.
41. Ohno, H., K. Hase, and K. Kawano. 2008. Antigen recognition, uptake and receptor on M cells. Clin. Immunol. Allergol. 19: 1-9.
42. Ueki, T., M. Mizuno, T. Uesu, T. Kiso, and T. Tsuji. 1995. Expression of ICAM-I on M cells covering isolated lymphoid follicles of the human colon. Acta Med. Okayama 49: 145-151.
43. Gullberg, E., A. V. Keita, S. Y. Salim, M. Andersson, K. D. Caldwell, J. D. Soderholm, and P. Artursson. 2006. Identification of cell adhesion molecules in the human follicle-associated epithelium that improve nanoparticle uptake into the Peyer's patches. J. Pharmacol. Exp. Ther. 319: 632-639.
44. Beyrer, C., A. W. Artenstein, S. Rugpao, H. Stephens, T. C. VanCott, M. L. Robb, M. Rinkaew, D. L. Birx, C. Khamboonruang, P. A. Zimmerman, et al. 1999. Epidemiologic and biologic characterization of a cohort of human immuno-deficiency virus type 1 highly exposed, persistently seronegative female sex workers in northern Thailand: Chiang Mai HEPS Working Group. J. Infect. Dis. 179: 59-67. (Pubitemid 29028339)
45. Mazzoli, S., D. Trabattoni, S. Lo Caputo, S. Piconi, C. Ble, F. Meacci, S. Ruzzante, A. Salvi, F. Semplici, R. Longhi, et al. 1997. HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals. Nat. Med. 3: 1250-1257.
46. Kaul, R., D. Trabattoni, J. J. Bwayo, D. Arienti, A. Zagliani, F. M. Mwangi, C. Kariuki, E. N. Ngugi, K. S. MacDonald, T. B. Ball, et al. 1999. HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers. AIDS 13: 23-29. (Pubitemid 29078060)
47. Barassi, C., A. Lazzarin, and L. Lopalco. 2004. CCR5-specific mucosal IgA in saliva and genital fluids of HIV-exposed seronegative subjects. Blood 104: 2205-2206. (Pubitemid 39297883)
48. Dean, M., M. Carrington, C. Winkler, G. A. Huttley, M. W. Smith, R. Allikmets, J. J. Goedert, S. P. Buchbinder, E. Vittinghoff, E. Gomperts, et al. 1996. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene: Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 273: 1856-1862.
49. Liu, R., W. A. Paxton, S. Choe, D. Ceradini, S. R. Martin, R. Horuk, M. E. MacDonald, H. Stuhlmann, R. A. Koup, and N. R. Landau. 1996. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86: 367-377. (Pubitemid 26272077)
50. Samson, M., F. Libert, B. J. Doranz, J. Rucker, C. Liesnard, C. M. Farber, S. Saragosti, C. Lapoumeroulie, J. Cognaux, C. Forceille, et al. 1996. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382: 722-725.
51. Pastori, C., B. Weiser, C. Barassi, C. Uberti-Foppa, S. Ghezzi, R. Longhi, G. Calori, H. Burger, K. Kemal, G. Poli, et al. 2006. Long-lasting CCR5 internalization by antibodies in a subset of long-term nonprogressors: a possible protective effect against disease progression. Blood 107: 4825-4833. (Pubitemid 43882634)
52. Roth-Walter, F., I. Scholl, E. Untersmayr, R. Fuchs, G. Boltz-Nitulescu, A. Weissenbock, O. Scheiner, F. Gabor, and E. Jensen-Jarolim. 2004. M cell targeting with Aleuria aurantia lectin as a novel approach for oral allergen immunotherapy. J. Allergy Clin. Immunol. 114: 1362-1368. (Pubitemid 39575891)
53. Foster, N., M. A. Clark, M. A. Jepson, and B. H. Hirst. 1998. Ulex europaeus 1 lectin targets microspheres to mouse Peyer's patch M-cells in vivo. Vaccine 16: 536-541. (Pubitemid 28044172)
54. Giannasca, P. J., K. T. Giannasca, A. M. Leichtner, and M. R. Neutra. 1999. Human intestinal M cells display the sialyl Lewis A antigen. Infect. Immun. 67: 946-953.
55. Sharma, R., E. J. van Damme, W. J. Peumans, P. Sarsfield, and U. Schumacher. 1996. Lectin binding reveals divergent carbohydrate expression in human and mouse Peyer's patches. Histochem. Cell Biol. 105: 459-465. (Pubitemid 26183669)